AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. financial statements

AN2 Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 35.17M10-K
Cash and equivalentsUSD 19.94M10-Q

AN2 Therapeutics, Inc. financials on 6ix · AN2 Therapeutics, Inc. on 6ix